Attached files
| file | filename |
|---|---|
| EX-10.69 - LOAN AGREEMENT DATED JULY 3, 2020, AMONG CELL MEDX CORP. AND DAVID JEFFS - Cell MedX Corp. | cmxc_ex1069.htm |
| EX-32.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex322.htm |
| EX-31.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex312.htm |
| EX-31.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex311.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - Cell MedX Corp. | cmxc_ex211.htm |
| EX-10.70 - LOAN AGREEMENT AND NOTE PAYABLE DATED AUGUST 31, 2020, AMONG CELL MEDX CORP. AND - Cell MedX Corp. | cmxc_ex1070.htm |
| EX-10.68 - LOAN AGREEMENT AND NOTE PAYABLE DATED APRIL 13, 2020, AMONG CELL MEDX CORP. AND - Cell MedX Corp. | cmxc_ex1068.htm |
| 10-K - ANNUAL REPORT - Cell MedX Corp. | cmxc_10k.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Cell MedX Corp. (the “Company”) on Form 10-K for the period ending May 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frank McEnulty, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: September 15, 2020
/s/Frank McEnulty
Frank McEnulty
Chief Executive Officer